| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 8 | 8 | 2002 | 2020 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 6 | 3 | 2008 | 2020 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 4 | 6 | 2008 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 3 | 3 | 2008 | 2019 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 2 | 1 | 2005 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 4 | 1990 | 2019 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.700 | None | 0.957 | 1 | 1 | 2000 | 2019 | ||||||||
|
B cell scaffold protein with ankyrin repeats 1 | 0.653 | 0.538 | 4.8E-12 |
|
disease | 0.700 | None | 0.955 | 1 | 2 | 2008 | 2019 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.700 | None | 0.926 | 1 | 1 | 2009 | 2019 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.670 | None | 0.875 | 1 | 1 | 2008 | 2015 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 3 | 1 | 1991 | 2016 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 1 | 1 | 1995 | 2019 | ||||||||
|
ubiquitin conjugating enzyme E2 L3 | 0.644 | 0.615 | 0.84 |
|
disease | 0.490 | None | 0.941 | 2 | 2 | 2008 | 2020 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.470 | None | 0.875 | 1 | 1 | 2008 | 2012 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.450 | strong | 1.000 | 1 | 2 | 1976 | 2015 | ||||||||
|
solute carrier family 15 member 4 | 0.805 | 0.269 | 1.9E-06 |
|
disease | 0.440 | None | 1.000 | 2 | 2 | 2009 | 2017 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
disease | 0.430 | None | 0.857 | 1 | 3 | 2009 | 2019 | ||||||||
|
RAS guanyl releasing protein 3 | 0.686 | 0.500 | 9.1E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2017 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2017 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.390 | None | 0.944 | 2 | 3 | 2008 | 2019 | ||||||||
|
LYN proto-oncogene, Src family tyrosine kinase | 0.603 | 0.615 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 2 | 2001 | 2010 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.786 | 1 | 1 | 1993 | 2017 | ||||||||
|
CD247 molecule | 0.539 | 0.731 | 1.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1998 | 2018 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1978 | 2014 |